Author Archives: Harvard Law School Forum on Corporate Governance and Financial Regulation

Stakeholder Principles in the COVID Era

The business community’s contribution: to be leaders of responsiveness and stewards of resilience As business leaders, we are experiencing how profoundly the COVID-19 emergency is affecting the world. Our employees face health risks in their daily lives, and challenges in performing their jobs. Our ecosystem of suppliers and customers is under extreme pressure. By doing […]

Click here to read the complete post
Posted in Corporate Social Responsibility, ESG, International Corporate Governance & Regulation, Practitioner Publications | Tagged , , , , , , | Comments Off on Stakeholder Principles in the COVID Era

Statement on Emerging Market Investments Disclosure and Financial Reporting Risks

The PCAOB’s Inability to Inspect Audit Work Papers in China Continues Introduction Over the past several decades, the portfolios of U.S. investors have become increasingly exposed to companies that are based in emerging markets or that otherwise have significant operations in emerging markets. This exposure includes investments in both U.S. issuers and foreign private issuers […]

Click here to read the complete post
Posted in Accounting & Disclosure, International Corporate Governance & Regulation, Practitioner Publications, Regulators Materials, Securities Litigation & Enforcement, Securities Regulation | Tagged , , , , , , , , , , , | Comments Off on Statement on Emerging Market Investments Disclosure and Financial Reporting Risks

COVID-19 and Corporate Governance: Key Issues for Public Company Directors

For almost all U.S. public companies, COVID-19 has created unique and very profound challenges. For the board of directors, which is charged with overseeing the short-term and long-term health of the corporation and its business prospects, navigating the COVID-19 crisis requires careful consideration of a range of issues under these unprecedented circumstances. This post outlines […]

Click here to read the complete post
Posted in Boards of Directors, Practitioner Publications | Tagged , , , , , , , , | 1 Comment

Codetermination: A Poor Fit for U.S. Corporations

The idea that corporations should be managed primarily in the best interest of shareholders has long had its critics. However, the practical relevance of that debate has remained limited for decades. As long as shareholders retain the right to select corporate managers, corporations will ultimately be managed in their interest. Moreover, there is little reason […]

Click here to read the complete post
Posted in Academic Research, Boards of Directors, Comparative Corporate Governance & Regulation, Corporate Elections & Voting, International Corporate Governance & Regulation | Tagged , , , , , , , , , , , | Comments Off on Codetermination: A Poor Fit for U.S. Corporations

Impact of COVID-19 on Executive and Director Compensation

As the COVID-19 pandemic and stay at home orders continue to change the way we live, work, and spend, corporations have been forced to continue evolving in response. Without an obvious rebound in consumer spending in sight, workforce reductions and furloughs are an unfortunate but necessary tactic to help companies weather the drought. The impacts […]

Click here to read the complete post
Posted in Accounting & Disclosure, Boards of Directors, Executive Compensation, Practitioner Publications | Tagged , , , , , , | Comments Off on Impact of COVID-19 on Executive and Director Compensation

Addressing Underwater Stock Options and Stock Appreciation Rights Amidst COVID-19

The coronavirus (COVID-19) pandemic and the ensuing market uncertainty, as well as recently enacted legislation, have upended the compensation and benefit programs of many companies. This post is based on the third memorandum in a series of client memoranda that we are preparing regarding how companies may wish to consider addressing their programs in this […]

Click here to read the complete post
Posted in Accounting & Disclosure, Executive Compensation, Institutional Investors, Practitioner Publications, Securities Regulation | Tagged , , , , , , , , , , , | Comments Off on Addressing Underwater Stock Options and Stock Appreciation Rights Amidst COVID-19

2020 Proxy Season Preview

Companies recognize the importance of environmental and social (E&S) factors and are giving consideration to a broader group of stakeholders to help mitigate risk. However, new regulations bring uncertainty to the future of environmental, social and governance (ESG) proposals. The rapid spread of the coronavirus is roiling global markets and testing companies’ abilities to handle […]

Click here to read the complete post
Posted in Accounting & Disclosure, Corporate Elections & Voting, ESG, Executive Compensation, Practitioner Publications, Securities Regulation | Tagged , , , , , , , , , , , , , , , | Comments Off on 2020 Proxy Season Preview

Is Financial Globalization in Reverse after the 2008 Global Financial Crisis? Evidence from Corporate Valuations

Before the 2008 global financial crisis (GFC), it seemed that financial globalization was increasing inexorably. For financial economists, one natural indicator of financial globalization is the extent to which similar firms are valued similarly across the globe. In a world of perfectly integrated financial markets, the same firm should be valued the same everywhere. Before […]

Click here to read the complete post
Posted in Academic Research, Empirical Research, Financial Crisis, International Corporate Governance & Regulation | Tagged , , , , , | Comments Off on Is Financial Globalization in Reverse after the 2008 Global Financial Crisis? Evidence from Corporate Valuations

The Impact of COVID-19 on Executive Compensation

The majority of the benefit and compensation provisions of the Coronavirus Aid Relief and Economic Security Act (the “CARES Act”) provide critical relief to companies and rank and file employees in light of the COVID-19 pandemic (see our previous blog posts on the impact of the CARES Act on health and welfare plans, on the impact on […]

Click here to read the complete post
Posted in Accounting & Disclosure, Executive Compensation, Practitioner Publications | Tagged , , , , , , , , , , , | Comments Off on The Impact of COVID-19 on Executive Compensation

ISS and Glass Lewis Guidances on Poison Pills during COVID-19 Pandemic

Last month, we described the increased threat of activists and acquirors seeking to capitalize on the COVID-19 sell-off to build positions in high-value companies at depressed prices. Even before the current crisis emerged, we recommended that all U.S. public companies regularly review their defense profile and have a shareholder rights plans “on the shelf.” For […]

Click here to read the complete post
Posted in Boards of Directors, Corporate Elections & Voting, Institutional Investors, Mergers & Acquisitions, Practitioner Publications | Tagged , , , , , , , , , , , | Comments Off on ISS and Glass Lewis Guidances on Poison Pills during COVID-19 Pandemic